Showing 3 of 3 recruiting trials for “clear-cell-sarcoma-of-kidney”
An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors
NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma
RecruitingNCT05231655 ↗
Ex VIvo DEtermiNed Cancer Therapy
👨⚕️ Sarah Danson, PhD, FRCP, University of Sheffield, Sheffield Teaching Hospitals NHS Foundation Trust📍 1 site📅 Started Jul 2021View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →